Immunization with a Modified Vaccinia Virus Expressing Simian Immunodeficiency Virus (SIV) Gag-Pol Primes for an Anamnestic Gag-Specific Cytotoxic T-Lymphocyte Response and Is Associated with Reduction of Viremia after SIV Challenge

The immunogenicity and protective efficacy of a modified vaccinia virus Ankara (MVA) recombinant expressing the simian immunodeficiency virus (SIV) Gag-Pol proteins (MVA-gag-pol) was explored in rhesus monkeys expressing the major histocompatibility complex (MHC) class I allele, MamuA*01. Macaques r...

Description complète

Détails bibliographiques

Publié dans:	J Virol
Auteurs principaux:	Seth, Aruna, Ourmanov, Ilnour, Schmitz, Jorn E., Kuroda, Marcelo J., Lifton, Michelle A., Nickerson, Christine E., Wyatt, Linda, Carroll, Miles, Moss, Bernard, Venzon, David, Letvin, Norman L., Hirsch, Vanessa M.
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 2000
Sujets:	Vaccines and Antiviral Agents
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC111738/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10684264/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.74.6.2502-2509.2000
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!